熱門資訊> 正文

BRIEF-Windtree Advances Lower Cost Manufacturing Of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel

2025-06-27 05:15

June 26 (Reuters) - Windtree Therapeutics Inc WINT.O:

WINDTREE ADVANCES LOWER COST MANUFACTURING OF PHEXXI, EVOFEM’S HORMONE-FREE, ON-DEMAND PRESCRIPTION CONTRACEPTIVE GEL
WINDTREE THERAPEUTICS: CONTRACT INKED WITH OUTSIDE U.S MANUFACTURER TO CUT PHEXXI MANUFACTURING COSTS BY OVER 50% BY END OF 2026
WINDTREE THERAPEUTICS INC: TECH TRANSFER UNDERWAY WITH VALIDATION BATCH MANUFACTURING EXPECTED TO BEGIN IN 2026

Source text: ID:nGNX21CYlX

Further company coverage: WINT.O

((Reuters.Briefs@thomsonreuters.com;))

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。